People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Pharma, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VIRxSYS Corp | — | Biotechnology | Series B | $44.6M | $39.7M | 2009 |
| EIP Pharma, Inc. | — | Pharma | Series B | $44.1M | $8.3M | 2023 |
| OurStage, Inc | — | Other Technology | Series A | $32.6M | $10.9M | 2009 |
| Community Education Centers Inc | — | Other | Series A | $5.0M | $75.7M | 2009 |
William Turner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Turner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DAVID MOORE | 1 | 13 |
| Gary Cohen | 1 | 6 |
| Daniel Raynor | 1 | 5 |
| Tim Pollack | 1 | 4 |
| Keith Kerman | 1 | 4 |
| Steve Pogorzelski | 1 | 4 |
| Paula Schmitz | 1 | 3 |
| John Roth | 1 | 3 |
| Robert Ackmann | 1 | 2 |
| Gerard Fleury | 1 | 2 |
| JOHN ALAM | 1 | 2 |
| John Costello | 1 | 2 |
| John Partilla | 1 | 2 |
| SYLVIE GREGOIRE | 1 | 2 |
| JEFF POULTON | 1 | 1 |
| Don Ienner | 1 | 1 |
| Tatjana May | 1 | 1 |
| MARWAN SABBAGH | 1 | 1 |
| KELLY BLACKBURN | 1 | 1 |
| FRANK ZAVRL | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.